• Aspen Neuro Bags $6.5M to Test Parkinson's Disease Stem Cell Therapy

    1 month ago - By Xconomy

    Nearly nine years ago Jeanne Loring and her colleagues at Scripps Research debuted a test that leveraged advances in genomics and data science to determine, without testing in animals, whether human stem cells were “pluripotent,” or able to become any type of cell in the body. Being able to prove that has become increasingly important as scientists look to induced pluripotent stem cells -mature, specialized cells that have been reprogrammed as immature cells, regaining the capability of becoming any type of cell-as material for new regenerative medicines. Now Loring and Andres Bratt-Leal...
    Read more ...